Zomedica Pharmaceuticals Corp.(ZOM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZOM Zomedica Pharmaceuticals Corp.

Trading 05-03 15:11:23 EDT

0.1432

+0.0012

+0.85%

High0.1485	Low0.1371	Vol6.68M
Open0.1422	D1 Closing0.1420	Amplitude8.03%
Mkt Cap140.33M	Tradable Cap137.95M	Total Shares979.95M
T/O961.82K	T/O Rate0.69%	Tradable Shares963.33M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ZOM","market":"US","secType":"STK","nameCN":"Zomedica Pharmaceuticals Corp.","latestPrice":0.1432,"timestamp":1714763439316,"preClose":0.142,"halted":0,"volume":6680710,"delay":0,"floatShares":963334719,"shares":979949668,"eps":-0.035235,"marketStatus":"Trading","change":0.0012,"latestTime":"05-03 15:11:23 EDT","open":0.1422,"high":0.1485,"low":0.1371,"amount":961822.6203852,"amplitude":0.080282,"askPrice":0.1432,"askSize":118,"bidPrice":0.1431,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-0.035235,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1714766400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":0.142,"preHourTrading":{"tag":"盘前","latestPrice":0.1444,"preClose":0.142,"latestTime":"09:27 EDT","volume":83691,"amount":11973.403558799999,"timestamp":1714742830700},"postHourTrading":{"tag":"盘后","latestPrice":0.1434,"preClose":0.142,"latestTime":"19:55 EDT","volume":79915,"amount":11437.7385,"timestamp":1714694144351},"volumeRatio":1.476742},"requestUrl":"/m/hq/s/ZOM","defaultTab":"news","newsList":[{"id":"2432673102","title":"Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2432673102","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2432673102?lang=en_us&edition=fundamental","pubTime":"2024-05-02 18:30","pubTimestamp":1714645800,"startTime":"0","endTime":"0","summary":"Intellectual property portfolio now includes 188 Patents and 131 Trademarks providing robust protection for the Company's product platforms. ANN ARBOR, MI / ACCESSWIRE / May 2, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the issuance of three new patents, bolstering the intellectual property protection for its revolutionary TRUFORMA diagnostic platform. The TRUFORMA system provides veterinary professionals with reference laboratory accuracy directly at the point of care, enhancing the health management of horses and companion animals.TRUFORMA technology represents a breakthrough in veterinary health diagnostics, employing highly sensitive proprietary Bulk Acoustic Wave  technology in a compact, easy-to-use device. This system utilizes disposable cartridges that are preloaded with reagents to minimize sample preparation and simplify the workflow, allowing veterinarians ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-strengthens-market-position-patents-103000951.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431500311","title":"Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2431500311","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2431500311?lang=en_us&edition=fundamental","pubTime":"2024-04-30 18:30","pubTimestamp":1714473000,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / April 30, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, May 9th, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its first quarter ended March 31, 2024. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Corp. Q1 2024 Financial Results Conference Call. For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, May 23, 2024, at 11:59 PM ET and can be accessed by dialing +1-844-512-2921  or +1-412-317-6671  and entering replay pin number: 72335729.Based in Ann Arbor, Michigan, Zomedica  is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-report-first-quarter-2024-103000685.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426169542","title":"Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2426169542","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2426169542?lang=en_us&edition=fundamental","pubTime":"2024-04-09 18:30","pubTimestamp":1712658600,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference on Wednesday, April 17, 9:30 a.m. - 10:00 a.m. ET, on Track 2.The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience. Scheduled 1x1 meetings with Zomedica's management team are also available for registered, qualified investor attendees.Attendees interested in viewing the live presentation can register for this event, at no cost, here: Virtual Healthcare Equity Conference Registration.About ZomedicaBased in Ann Arbor, Michigan, Zomedica  is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-present-noble-capital-markets-103000992.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424709847","title":"Zomedica Achieves Record Revenue and Strong Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2424709847","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2424709847?lang=en_us&edition=fundamental","pubTime":"2024-04-02 05:37","pubTimestamp":1712007478,"startTime":"0","endTime":"0","summary":"Zomedica Pharma (ZOM) has released an update. Zomedica Corp. has announced a record-breaking revenue of $7.3 million for the fourth quarter of 2023...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zomedica-achieves-record-revenue-and-strong-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zomedica-achieves-record-revenue-and-strong-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2424764117","title":"Zomedica Q4 2023 GAAP EPS $(0.02), Sales $7.337M Beat $7.000M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2424764117","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2424764117?lang=en_us&edition=fundamental","pubTime":"2024-04-02 04:28","pubTimestamp":1712003297,"startTime":"0","endTime":"0","summary":"Zomedica (AMEX:ZOM) reported quarterly losses of $(0.02) per share.  The company reported quarterly sales of $7.337 million which beat the analyst consensus estimate of $7.000 million by 4.81 percent.  This is a 19.17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38033632/zomedica-q4-2023-gaap-eps-0-02-sales-7-337m-beat-7-000m-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2424779081","title":"Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity","url":"https://stock-news.laohu8.com/highlight/detail?id=2424779081","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2424779081?lang=en_us&edition=fundamental","pubTime":"2024-04-02 04:05","pubTimestamp":1712001900,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today reported consolidated financial results for the fourth quarter and year-ended December 31, 2023. All figures are in US dollars unless otherwise stated.\"The fourth quarter capped off another record quarter and year for Zomedica. On the strength of our highest revenue quarter ever, we grew full year revenue by over 33%, due to early adoption of newly launched products in our Diagnostics segment, and continued strength in our Therapeutic Devices segment,\" commented Zomedica Chief Executive Officer, Larry Heaton.Revenue for 2023 grew 33% to $25.2 million, compared to 2022 revenue of nearly $19 million, primarily driven by increases in sales of Therapeutic Devices, which grew 28% over the prior year, and increases in sales of Diagnostics, which grew 252% over the prior year, primarily driven by an","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-reports-record-revenue-7-200500584.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424072018","title":"The Next Millionaire-Makers: 3 Penny Stocks With Massive Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2424072018","media":"InvestorPlace","top":-1,"share":"https://ttm.financial/m/news/2424072018?lang=en_us&edition=fundamental","pubTime":"2024-04-02 03:12","pubTimestamp":1711998731,"startTime":"0","endTime":"0","summary":"Explore the high return potential of penny stocks in health care equipment, passenger airlines and pharmaceuticals industries.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/04/the-next-millionaire-makers-3-penny-stocks-with-massive-upside-potential/","is_publish_highlight":false,"gpt_icon":0},{"id":"2424202921","title":"Notable earnings after Monday's close","url":"https://stock-news.laohu8.com/highlight/detail?id=2424202921","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424202921?lang=en_us&edition=fundamental","pubTime":"2024-04-01 05:35","pubTimestamp":1711920951,"startTime":"0","endTime":"0","summary":"Major earnings expected after the bell on Monday include:. Other earnings slated for release after Monday's close include:. ACOR,   OTCPK:EGLXF,   FLNT,   OTCQX:GDNSF,   IZEA,   OTCQX:KNTNF,   LLAP,   MVST,   PPSI,   PVH,   VTSI,   YTEN. For Seeking Alpha's full earnings season calendar, click here.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4085376-notable-earnings-after-mondays-close","is_publish_highlight":false,"gpt_icon":0},{"id":"2419974114","title":"Zomedica Strives to Maintain NYSE Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2419974114","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2419974114?lang=en_us&edition=fundamental","pubTime":"2024-03-15 21:37","pubTimestamp":1710509848,"startTime":"0","endTime":"0","summary":"Zomedica Pharma (ZOM) has released an update. Zomedica Corp. is actively engaging with NYSE American to address compliance issues after failing to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zomedica-strives-to-maintain-nyse-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zomedica-strives-to-maintain-nyse-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2419676722","title":"Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2419676722","media":"StreetInsider","top":-1,"share":"https://ttm.financial/m/news/2419676722?lang=en_us&edition=fundamental","pubTime":"2024-03-14 18:31","pubTimestamp":1710412260,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / March 14, 2024 / Zomedica Corp. (NYSE American:ZOM) (\"Zomedica\" or the \"Company\"), a veterinary health company offering point-of-care diagnostics and therapeutic products ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22929173","is_publish_highlight":false,"gpt_icon":0},{"id":"2417490600","title":"Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2417490600","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2417490600?lang=en_us&edition=fundamental","pubTime":"2024-03-05 19:30","pubTimestamp":1709638200,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / March 5, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Small Cap Conference, taking place virtually on March 14th, 2024.The Company's presentation will take place at 10:00 am ET on Thursday, March 14, 2024, and can be accessed directly on the official Sidoti Conference website.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-present-sidoti-small-cap-113000228.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2410812851","title":"3 High-Reward Penny Stocks to Uncover Big Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2410812851","media":"InvestorPlace","top":-1,"share":"https://ttm.financial/m/news/2410812851?lang=en_us&edition=fundamental","pubTime":"2024-02-12 00:22","pubTimestamp":1707668563,"startTime":"0","endTime":"0","summary":"Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/02/3-high-reward-penny-stocks-to-uncover-big-gains/","is_publish_highlight":false,"gpt_icon":0},{"id":"2410042813","title":"Stride, Inc. Announces Sudden Resignation of Director Robert Cohen","url":"https://stock-news.laohu8.com/highlight/detail?id=2410042813","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2410042813?lang=en_us&edition=fundamental","pubTime":"2024-02-10 17:34","pubTimestamp":1707557674,"startTime":"0","endTime":"0","summary":"Stride (LRN) has released an update to notify the public and investors about its officers. Robert L. Cohen has abruptly resigned from his positions...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/stride-inc-announces-sudden-resignation-of-director-robert-cohen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/stride-inc-announces-sudden-resignation-of-director-robert-cohen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2409078797","title":"Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2409078797","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2409078797?lang=en_us&edition=fundamental","pubTime":"2024-02-08 19:30","pubTimestamp":1707391800,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / February 8, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the continuation of its veterinary education mission through recent and upcoming presentations at the Veterinary Meeting and Expo  and Western Veterinary Conference  meetings.\"At Zomedica, we feel strongly about giving back to the veterinary community. These meetings are amongst the most prominent and well-attended annual educational symposiums in veterinary healthcare, with combined attendance of over 47,000 veterinary professionals,\" commented Nicole Westfall, Zomedica's Senior Vice-President of Marketing. \"They not only support the continuing education of veterinary healthcare professionals but also provide high visibility to the many benefits of Zomedica's innovative diagnostic and therapeutic products. In 2023, over 150 continuing education hours were provided to veterinary profess","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-announces-sponsorship-educational-presentations-113000055.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2409718862","title":"Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)","url":"https://stock-news.laohu8.com/highlight/detail?id=2409718862","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2409718862?lang=en_us&edition=fundamental","pubTime":"2024-02-07 05:30","pubTimestamp":1707255000,"startTime":"0","endTime":"0","summary":"\"We agree with the board that it is in the best interest of the Company to reduce the number of shares of common stock outstanding and thereby attempt to proportionally raise the per-share price of the Company's common stock.\". This news comes shortly after the ISS report dated January 25, 2024, wherein ISS noted that, \"A vote FOR this proposal is warranted given that the reverse stock split may enable the company to maintain listing of its common stock on the NYSE American.\". \"We welcome the favorable recommendations from both ISS and Glass Lewis and are pleased that both proxy advisory firms recognize the compelling merits of the proposed reverse stock split,\" noted Zomedica CEO Larry Heaton.Zomedica reminds stockholders that every vote is important, no matter how many or few shares it represents. If you have already submitted a proxy, you may change your vote prior to the Special Meeting by voting again using the same m","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/leading-independent-proxy-advisory-firm-213000706.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2409458436","title":"3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2409458436","media":"InvestorPlace","top":-1,"share":"https://ttm.financial/m/news/2409458436?lang=en_us&edition=fundamental","pubTime":"2024-02-06 01:40","pubTimestamp":1707154804,"startTime":"0","endTime":"0","summary":"Zomedica : Its record-breaking revenues demonstrate substantial growth, focusing on organic growth and strategic acquisitions.Blade Air : The company enjoys massive revenue growth, particularly in the vital passenger segment, and is driven by strategic expansions.Sundial Growers : It achieved positive net cash and free cash flow, signaling financial stability and potential for internal growth funding.Three companies attained solid growth through strategic initiatives, positive financial indicators, and market positioning.Additionally, the company’s strategic plan to acquire, integrate and grow is proven effective. The record-breaking quarter demonstrates Zomedica’s ability to efficiently adapt and integrate acquired entities. Also, this highlights its capacity to foster organic growth within its existing operations.Other strategic moves are acquiring Structured Monitoring Products  and the VetGuardian platform. This provides exclusive commercial rights and enhances the quality of care ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/02/3-hidden-gem-penny-stocks-that-could-yield-life-changing-wealth/","is_publish_highlight":false,"gpt_icon":0},{"id":"2407368395","title":"Open Letter to Zomedica Shareholders from your Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2407368395","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2407368395?lang=en_us&edition=fundamental","pubTime":"2024-01-31 19:30","pubTimestamp":1706700600,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / January 31, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Chief Executive Officer Larry Heaton has issued an open letter to shareholders regarding the upcoming reverse split vote. The full letter is available on the Company's website at Events & Presentations | Zomedica Inc. and is published below:. After reviewing feedback from you, our shareholders, and IR firms and reading the various message boards, I would like to make a simple request of our shareholders: Please do your own due diligence.Of course, I strongly encourage shareholders to vote FOR the reverse split, and we've been very forthright about the many potential benefits to your Company, including:. Removing barriers to investing by new individual/retail investors who do not invest in \"penny stocks\". This includes family offices and high net worth individuals, many of whom hav","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/open-letter-zomedica-shareholders-chief-113000279.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2407332711","title":"Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2407332711","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2407332711?lang=en_us&edition=fundamental","pubTime":"2024-01-30 19:30","pubTimestamp":1706614200,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / January 30, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners 2024 Investor Select Conference, taking place virtually on February 1st, 2024.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-participate-lytham-partners-2024-113000511.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2406731472","title":"Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote \"FOR\" Proposed Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2406731472","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2406731472?lang=en_us&edition=fundamental","pubTime":"2024-01-26 05:35","pubTimestamp":1706218500,"startTime":"0","endTime":"0","summary":"In its report dated January 25, 2024, ISS noted that, \"A vote FOR this proposal is warranted given that the reverse stock split may enable the company to maintain listing of its common stock on the NYSE American.\". Larry Heaton, Chief Executive Officer of Zomedica, commented, \"We are pleased that ISS recommends that our stockholders vote in favor of the reverse stock split. ISS recognizes that the reverse split will enable us to avoid delisting from the NYSE American, which we believe would adversely impact the Company's market valuation and our shareholders' liquidity. We believe that in addition the reverse split will enable Zomedica to attract a broader range of investors, draw equity research analyst interest, and be considered for inclusion in stock indices. Your vote ‘FOR' the proposal will allow us to stay focused on growing the business towards profitability while helping pets and pet parents get the best care from their veterinarians. We urge all shareholders to follow the rec","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/u.mnj5UHnARyn69tPIIgqg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/676315c26992730cac110adf6cc6dbd2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/leading-proxy-advisory-firm-iss-213500105.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2404839728","title":"Zomedica says Q4 revenue is expected to be over $7M","url":"https://stock-news.laohu8.com/highlight/detail?id=2404839728","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2404839728?lang=en_us&edition=fundamental","pubTime":"2024-01-18 05:25","pubTimestamp":1705526708,"startTime":"0","endTime":"0","summary":"Zomedica  on Wednesday said revenue for Q4 is expected to be over $7 million, compared to Q4 2022 revenue of $6.2 million, primarily driven by strong performance across many product lines, highlighted by a record quarter in the Therapeutic Device segment. Revenue for 2023 is expected to be over $25 million, an increase of over 32% compared to 2022 revenue of $18.9 million. Cash, Cash Equivalents, and Available-for-Sale Securities are expected to be just over $100 million at December 31, 2023. The company expects FY24 revenue in the range of $31 to $35 million, an increase of approximately 40% at the high end of the range, over full year 2023 revenue of over $25 million. Source: Press Release    More on Zomedica  Zomedica Corp.  Q3 2023 Earnings Call Transcript Financial information for Zomedica","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4055797-zomedica-says-q4-revenue-is-expected-to-be-over-7m","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zomedica.com","stockEarnings":[{"period":"1week","weight":0.0915},{"period":"1month","weight":0.0143},{"period":"3month","weight":0.0782},{"period":"6month","weight":-0.2324},{"period":"1year","weight":-0.2718},{"period":"ytd","weight":-0.2907}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0266},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.0625}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform and VetGuardian, a zero-touch vital signs remote monitoring system, as well as Revo Squared imaging platform comprising diagnostic imaging products and services for use in animal health. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.381112},{"month":2,"riseRate":0.857143,"avgChangeRate":0.21916},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.15261},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.097509},{"month":5,"riseRate":0,"avgChangeRate":-0.091874},{"month":6,"riseRate":0.5,"avgChangeRate":0.062008},{"month":7,"riseRate":0.5,"avgChangeRate":-0.049297},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.005469},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.085039},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.09468},{"month":11,"riseRate":0.333333,"avgChangeRate":0.144334},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.018229}],"exchange":"AMEX","name":"Zomedica Pharmaceuticals Corp.","nameEN":"Zomedica Pharmaceuticals Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zomedica Pharmaceuticals Corp.(ZOM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zomedica Pharmaceuticals Corp.(ZOM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zomedica Pharmaceuticals Corp.,ZOM,Zomedica Pharmaceuticals Corp.股票,Zomedica Pharmaceuticals Corp.股票老虎,Zomedica Pharmaceuticals Corp.股票老虎国际,Zomedica Pharmaceuticals Corp.行情,Zomedica Pharmaceuticals Corp.股票行情,Zomedica Pharmaceuticals Corp.股价,Zomedica Pharmaceuticals Corp.股市,Zomedica Pharmaceuticals Corp.股票价格,Zomedica Pharmaceuticals Corp.股票交易,Zomedica Pharmaceuticals Corp.股票购买,Zomedica Pharmaceuticals Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zomedica Pharmaceuticals Corp.(ZOM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zomedica Pharmaceuticals Corp.(ZOM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction